Quanterix Corporation $QTRX Stock Holdings Lifted by Russell Investments Group Ltd.

Key Points

• Russell Investments Group Ltd. increased its stake in Quanterix Corporation by 51.1%, now owning 606,787 shares valued at approximately $3.95 million.
• Quanterix has received mixed ratings from analysts, with price targets being revised down; Canaccord Genuity now targets $5.00, down from $12.00.
• Quanterix reported a loss of ($0.47) EPS for the last quarter, missing estimates, and anticipates a yearly loss of ($0.98) EPS.

Russell Investments Group Ltd. lifted its position in Quanterix Corporation (NASDAQ:QTRX - Free Report) by 51.1% during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 606,787 shares of the company's stock after buying an additional 205,311 shares during the period. Russell Investments Group Ltd. owned approximately 1.56% of Quanterix worth $3,950,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Tower Research Capital LLC TRC raised its stake in shares of Quanterix by 219.1% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,702 shares of the company's stock worth $61,000 after buying an additional 3,915 shares in the last quarter. Aaron Wealth Advisors LLC acquired a new stake in shares of Quanterix during the first quarter worth $79,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Quanterix during the first quarter worth $98,000. Canada Pension Plan Investment Board raised its position in shares of Quanterix by 64.5% during the fourth quarter. Canada Pension Plan Investment Board now owns 10,200 shares of the company's stock worth $108,000 after purchasing an additional 4,000 shares during the period. Finally, ProShare Advisors LLC acquired a new stake in shares of Quanterix during the fourth quarter worth $108,000. Institutional investors own 86.48% of the company's stock.

Quanterix Stock Performance

Shares of QTRX stock traded down $0.07 on Thursday, reaching $4.54. 542,141 shares of the company's stock traded hands, compared to its average volume of 815,792. Quanterix Corporation has a 12-month low of $4.05 and a 12-month high of $15.85. The company has a market capitalization of $210.97 million, a P/E ratio of -2.49 and a beta of 1.07. The business's 50 day moving average price is $5.65 and its two-hundred day moving average price is $6.00.

Quanterix (NASDAQ:QTRX - Get Free Report) last issued its quarterly earnings results on Thursday, August 7th. The company reported ($0.47) earnings per share for the quarter, missing analysts' consensus estimates of ($0.41) by ($0.06). Quanterix had a negative net margin of 56.04% and a negative return on equity of 18.41%. The business had revenue of $24.48 million for the quarter, compared to analysts' expectations of $29.73 million. Quanterix has set its FY 2025 guidance at EPS. Research analysts predict that Quanterix Corporation will post -0.98 earnings per share for the current year.

Insiders Place Their Bets

In other Quanterix news, Director William P. Donnelly purchased 93,113 shares of the stock in a transaction dated Friday, June 6th. The shares were acquired at an average price of $5.44 per share, for a total transaction of $506,534.72. Following the completion of the acquisition, the director owned 139,094 shares of the company's stock, valued at $756,671.36. This represents a 202.50% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director David R. Walt bought 131,869 shares of the stock in a transaction on Friday, June 6th. The stock was purchased at an average price of $5.43 per share, for a total transaction of $716,048.67. Following the purchase, the director directly owned 1,628,802 shares of the company's stock, valued at approximately $8,844,394.86. This represents a 8.81% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have bought 463,113 shares of company stock worth $2,625,444 in the last quarter. 6.90% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on the company. Leerink Partnrs lowered Quanterix from a "strong-buy" rating to a "hold" rating in a research report on Wednesday, April 30th. Wall Street Zen lowered Quanterix from a "hold" rating to a "sell" rating in a research report on Thursday, May 22nd. Leerink Partners reaffirmed a "market perform" rating and set a $8.00 target price (down from $12.00) on shares of Quanterix in a research report on Wednesday, April 30th. Finally, Canaccord Genuity Group reaffirmed a "hold" rating and set a $5.00 target price (down from $12.00) on shares of Quanterix in a research report on Monday, August 11th. One equities research analyst has rated the stock with a Buy rating and four have issued a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $11.75.

Quanterix Company Profile

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications.